MIRA Pharmaceuticals, Inc. Share Price & Technical Analysis
MIRA · $1.06 (+4.95%)
Healthcare / Drug Manufacturers - General
$1.06
+4.95%
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical mari…
Price chart
Seasonality
Jun has 0 positive and 3 negative years (last 4 years shown)
-9% return in Jun, -16% avg return in past 3 year Jun month.
-28% return in 2026, 54% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -20% | 8% | -8% | -9% | 10% | -9% | – | – | – | – | – | – | -28% |
| 25 | 0% | -17% | 0% | 20% | 17% | -8% | 33% | -12% | 0% | 31% | -6% | 7% | 65% |
| 24 | -18% | 11% | 10% | -18% | -11% | -25% | 250% | -10% | -32% | 69% | -41% | -15% | 170% |
| 23 | – | – | – | – | – | – | – | -10% | -25% | -60% | 94% | -72% | -74% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial. It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$43.70M
P/E ratio
—
52W high
$2.45
52W low
$0.90
Volume
1,27,396
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is MIRA Pharmaceuticals, Inc. share price today?
- MIRA Pharmaceuticals, Inc. (MIRA) last traded around $1.06 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does MIRA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for MIRA. Download the app for real-time alerts.
- How can I analyze MIRA Pharmaceuticals, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.